The Aroon Indicator for PLSE entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 206 similar instances where the Aroon Indicator formed such a pattern. In 181 of the 206 cases the stock moved lower. This puts the odds of a downward move at 88%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for PLSE crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on PLSE as a result. In 77 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on October 22, 2026. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in 51 of 56 cases over the following month. The odds of a continued upward trend are 90%.
PLSE moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLSE advanced for three days, in 227 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
PLSE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. PLSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PLSE's P/B Ratio (37.762) is very high in comparison to the industry average of (4.961). P/E Ratio (-45.026) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. PLSE's P/S Ratio (2500.000) is very high in comparison to the industry average of (56.876).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TMCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 43 cases where TMCI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TMCI's RSI Oscillator exited the oversold zone, 30 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on TMCI as a result. In 72 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for TMCI just turned positive on October 21, 2026. Looking at past instances where TMCI's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
Following a +5.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMCI advanced for three days, in 204 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
TMCI moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TMCI crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for TMCI entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.109) is normal, around the industry mean (2.874). P/E Ratio (-4.652) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.430) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TMCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
PLSE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 37 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 96 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PLSE | TMCI | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 87% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 72% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 86% |
| Advances ODDS (%) | 1 day ago 88% | 1 day ago 76% |
| Declines ODDS (%) | 7 days ago 85% | 15 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 78% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PLSE’s FA Score shows that 0 FA rating(s) are green while TMCI’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PLSE’s TA Score shows that 5 TA indicator(s) are bullish while TMCI’s TA Score has 6 bullish TA indicator(s).
PLSE (@Pharmaceuticals: Other) experienced а +10.77% price change this week, while TMCI (@Medical/Nursing Services) price change was +2.48% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
PLSE is expected to report earnings on Nov 04, 2026.
TMCI is expected to report earnings on Nov 05, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with NVST. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To PLSE | 1D Price Change % | ||
|---|---|---|---|---|
| PLSE | 100% | +2.67% | ||
| NVST - PLSE | 39% Loosely correlated | +3.36% | ||
| CERS - PLSE | 38% Loosely correlated | -3.35% | ||
| CLPT - PLSE | 32% Poorly correlated | N/A | ||
| ARAY - PLSE | 32% Poorly correlated | -2.19% | ||
| TMCI - PLSE | 32% Poorly correlated | +3.38% | ||
More | ||||
A.I.dvisor indicates that over the last year, TMCI has been loosely correlated with UTMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TMCI jumps, then UTMD could also see price increases.
| Ticker / NAME | Correlation To TMCI | 1D Price Change % | ||
|---|---|---|---|---|
| TMCI | 100% | +3.38% | ||
| UTMD - TMCI | 48% Loosely correlated | +0.46% | ||
| GMED - TMCI | 45% Loosely correlated | +3.79% | ||
| CRL - TMCI | 39% Loosely correlated | -1.51% | ||
| AZTA - TMCI | 39% Loosely correlated | -2.04% | ||
| MTD - TMCI | 39% Loosely correlated | +0.40% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VFH | 137.66 | 1.62 | +1.19% |
| Vanguard Financials ETF (VFH) | |||
| RA | 11.65 | -0.01 | -0.09% |
| Brookfield Real Assets Income Fund | |||
| WCAP | 9.33 | -0.05 | -0.55% |
| WarCap Unconstrained Equity ETF (WCAP) | |||
| BFEB | 54.15 | -0.39 | -0.72% |
| Innovator U.S. Equity Buffer ETF - February (BFEB) | |||
| RIOX | 8.79 | -1.68 | -16.05% |
| Tidal Trust II Defiance Daily Target 2X Long RIOT ETF | |||